Abstract

COVID-19 has become a global health hazard and its high infectivity is worrying. This virus can infect anyone and can be more severe in people who have comorbid illnesses. One of the most common comorbidities in COVID-19 patients is type 2 diabetes mellitus. Chest radiography can be used to predict prognosis and mortality in COVID-19 patients. One of the scoring used is the Brixia score which serves to assess the severity of the lung based on certain indicators. There are not many studies that discuss the mortality rate of COVID-19 patients with comorbid diabetes mellitus based on the radiographic profile as measured by the Brixia score assessment. Therefore, this study aims to determine the correlation between the mortality rate of comorbid COVID-19 patients with type 2 diabetes mellitus with the severity of chest radiography using the Brixia score. This study used an analytic observational study with a cross-sectional approach. The subjects were 60 COVID-19 patients with type 2 diabetes mellitus who met the inclusion and exclusion criteria. Sampling was done by purposive sampling technique and the data obtained were analyzed using the contingency coefficient test. There was a significant relationship between the mortality rate of patients with COVID-19 comorbid type 2 diabetes mellitus and the severity of chest radiography using the Brixia score (p<0.001; p<0.05). There was a relationship between the mortality rate of COVID-19 patients with type 2 diabetes mellitus and the severity of chest radiography treated in the ICU of RSUD Dr. Moewardi, Surakarta

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call